ANI Pharmaceuticals
ANIP
NZ$107.72
Share price
-3.46%
Change (1 day)
0.07%
Change (1 year)
Categories
Earnings for ANI Pharmaceuticals (ANIP)
Earnings in 2025 (TTM): -NZ$42.55 Million
According to ANI Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.67 Billion. In 2024 the company made an earning of -NZ$37.27 Million a decrease over its 2023 earnings that were of NZ$33.34 Million. The earnings displayed on this page is the company's Pretax Income.
Earnings history for ANI Pharmaceuticals from 2000 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | -NZ$42.55 Million | 14.15% |
| 2024 | -NZ$37.27 Million | -211.78% |
| 2023 | NZ$33.34 M | -131.71% |
| 2022 | -NZ$0.11 Billion | 11.79% |
| 2021 | -NZ$94.06 Million | 115.92% |
| 2020 | -NZ$43.57 Million | -922.36% |
| 2019 | NZ$5.29 M | -84.26% |
| 2018 | NZ$33.64 M | 22.64% |
| 2017 | NZ$27.43 M | 88.4% |
| 2016 | NZ$14.56 M | -60.07% |
| 2015 | NZ$36.46 M | 12.15% |
| 2014 | NZ$32.51 M | -899.29% |
| 2013 | -NZ$4.07 Million | -91.27% |
| 2012 | -NZ$46.59 Million | -46.02% |
| 2011 | -NZ$86.32 Million | 17.96% |
| 2010 | -NZ$73.18 Million | 18% |
| 2009 | -NZ$62.01 Million | 103.96% |
| 2008 | -NZ$30.41 Million | 128.68% |
| 2007 | -NZ$13.3 Million | -330.34% |
| 2006 | NZ$5.77 M | -136.98% |
| 2005 | -NZ$15.61 Million | -24.17% |
| 2004 | -NZ$20.59 Million | 102.51% |
| 2003 | -NZ$10.17 Million | 58.68% |
| 2002 | -NZ$6.41 Million | 39.58% |
| 2001 | -NZ$4.59 Million | -24.1% |
| 2000 | -NZ$6.05 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | NZ$0.60 B | -1,414.01% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | -NZ$7.69 Million | -83.39% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | NZ$0.76 B | -1,747.31% | 🇮🇱 Israel |
 Pfizer PFE | NZ$17.35 B | -37,621.77% | 🇺🇸 USA |
 Lannett Company LCI | -NZ$0.34 Billion | 619.55% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -NZ$0.37 Billion | 688.13% | 🇺🇸 USA |
 Cardinal Health CAH | NZ$3.77 B | -8,264.01% | 🇺🇸 USA |
 Novartis NVS | NZ$25.03 B | -54,229.17% | 🇨🇭 Switzerland |
 Royalty Pharma RPRX | NZ$3.38 B | -7,411.54% | 🇬🇧 UK |